Yonsei University clinical trial pipeline

7 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 4 with minor changes only.

1. Notable

   Baseline Tumor Genomic Profiling and Circulating Tumor DNA in…Baseline Tumor Genomic Profiling and Circulating Tumor DNA in Neoadjuvant Chemoimmunotherapy for Stage IB-III Non-Small Cell Lung Cancer

   Primary completion pushed from Feb 28, 2026 to Dec 31, 2026

   Also in this update: Enrollment increased: 100 → 300 participants; Study completion pushed from Jun 30, 2029 to Dec 31, 2029

   Yonsei University·Not specified· NCT06907160· Registry history of NCT06907160 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   BEACON-AA · Apixaban With or Without Clopidogrel in Stroke…BEACON-AA · Apixaban With or Without Clopidogrel in Stroke · Atrial Fibrillation and Cerebral Atherosclerosis

   Primary endpoint(s) modified

   Also in this update: Recruitment opened

   Yonsei University·Phase 4· NCT07237308· Registry history of NCT07237308 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

3. Notable

   GWPCI · Gangwon PCI Prospective Registry

   Primary endpoint(s) modified

   Also in this update: Enrollment increased: 5000 → 10000 participants; Interventions modified

   Yonsei University·Not specified· NCT02038127· Registry history of NCT02038127 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.